Ely Benaim - 10 May 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Medical Officer
Signature: By: /s/ Steven Robbins, Attorney in Fact for Ely Benaim
Issuer symbol: NVCR
Transactions as of: 10 May 2022
Net transactions value: -$265,646
Form type: 4
Filing time: 12 May 2022, 16:30:12 UTC
Previous filing: 07 Mar 2022
Next filing: 07 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	$134,877	-2,070	-5.3%	$65.16	36,981	10 May 2022	Direct	F1, F2
transaction	NVCR	Ordinary Shares	Sale	$130,769	-2,135	-5.8%	$61.25	34,846	11 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Amended total to correct prior mathematical error.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Amended total to correct prior mathematical error.